- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Myeloma is a type of bone marrow cancer. Bone marrow is the spongy tissue in the centre of some bones that produces the body’s blood cells. It is usually called multiple myeloma because the cancer often affects several areas of the body, such as the spine, skull, pelvis, and ribs.
Showing 1–12 of 14 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
2 mg |
-80°C |
2018.11 |
212,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
2 mg |
-80°C |
2019.05 |
212,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
4 mg |
-80°C |
2023.11 |
354,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
4 mg |
-80°C |
2024.11 |
354,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
2 mg |
-80°C |
2018.01 |
212,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
3 mg |
-80°C |
2018.04 |
304,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
2 mg |
-80°C |
2019.09 |
212,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
2 mg |
-80°C |
2021.01 |
212,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
2 mg |
-80°C |
2023.07 |
212,00 € |
||
SLAMF7 |
Monoclonal Antibody |
Empliciti® |
25 mg/mL |
– |
10 mg |
-80°C |
2026.10 |
384,00 € |
||
SLAMF7 |
Monoclonal Antibody |
Empliciti® |
25 mg/mL |
– |
6 mg |
-80 °C |
2022.09 |
278,00 € |
||
SLAMF7 |
Monoclonal Antibody |
Empliciti® |
25 mg/mL |
– |
6 mg |
-80°C |
2024.02 |
278,00 € |
||
CD38 |
Monoclonal Antibody |
Sarclisa® |
20 mg/mL |
– |
2 mg |
tba |
tba |
243,00 € |
||
B cell maturation antigen , CD3 |
Bispecific Antibody |
Tecvayli® |
10 mg/mL |
– |
1 mg |
-80°C |
2024.10 |
410,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany